Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2024 Feb 7;76(3):366–375. doi: 10.1002/acr.25252

Table 3.

Quality assessment of the three Mendelian randomization assumptions for studies reporting associations for lifestyle-related and other exposures at p > 0.05

MR Assumption
Exposure Study Effect of exposure on outcome (per SD increase) p-value 1 2/3
MR Egger performed Support
Sleep
Insomnia 24 (40) 1.22 (1.15 – 1.30) 8.05E-10 ++ ++ ++
Sleep duration 24 (40) 0.99 (0.99 – 1.00) 2.75E-02 ++ ++ ++
Short sleep duration 24 (40) 1.04 (1.02 – 1.07) 2.20E-03 ++ ++ ++
Smoking
Lifetime smoking 10 (21) 2.23 (1.85 – 2.68) 1.24E-17 ++ ++ ++
Smoking quantity (# cigs) 18 (41) 0.84 (0.74 – 0.96) 0.008 ++ ++ ++
Smoking behavior 20 (42) 0.94 (0.90 – 0.99) 0.035 + ++ +
Education
Education (yrs schooling) 15 (43) 0.95 (0.91 – 0.97) NP ++ ++ ++
Education (yrs schooling) 37 (26) 0.78 (0.60 – 1.00) 0.048 ++ ++ +
Education (yrs schooling) 45 (14) 0.84 (0.73 – 0.95) 0.007 ++ 0 +
Educational attainment 10 (21) 0.59 (0.54 – 0.64) 3.08E-37 ++ ++ ++
Coffee
Coffee consumption 19 (44) 1.46 (1.04 – 2.04) 0.025 + ++ 0
Coffee consumption 39 (45) 1.01 (1.00 – 1.02)* 0.006 ++ ++ ++
Coffee consumption 25 (46) 1.23 (1.11 – 1.35) 4.46E-05 ++ ++ ++
Other
Bone mineral density 9 (20) 1.18 (1.04 – 1.35) 2.92E-08 ++ ++ ++
Bone mineral density 12 (18) 1.27 (1.03 – 1.55) 0.024 ++ ++ +
Ischemic stroke 3 (47) 1.03 (1.00 – 1.07) 0.036 ++ ++ +
Major depression 1 (48) 1.21 (1.15 – 1.28) 2.67E-13 ++ 0 +
Major depressive disorder 38 (49) 1.27 (1.18 – 1.37) 2.36E-08 ++ 0 +
Gut microbiota 35 (50) NP < 0.05 + ++ +
Plasma ADAMTS5 levels 40 (16) 0.98 (0.97 – 0.99) 0.005 ++ 0 ++
Social isolation 41 (51) 1.20 (1.10 – 1.31) NP ++ ++ ++
*

effect size reported for a 1% increase in coffee consumption.

See footnote in Table 1 and 2 for assessment of MR assumptions.